Covington & Burling LLP

Product Liability & Mass Torts Department

USA - Nationwide
Current View:

This content is provided by Chambers. Learn more about our methodology

What the team is known for Dynamic group that maintains a strong position in the nationwide market, evidenced by notable trial victories in the pharmaceutical space. Also handles complex cases in other product areas, including mass torts and class actions involving construction and consumer product industries. Frequently called upon to litigate major multidistrict matters and advise on appeals. Also notably expert in product recall investigations and enforcement actions.

Strengths One client states: "They are the sharpest minds out there. Nothing gets past them and their analysis. They assemble a full team to fulfill their client's needs."

Sources agree that Covington & Burling is "excellent as national coordinating counsel and handling complex large litigation, trying cases and doing everything from start to finish."

Work highlights Acted for Bayer on the Roundup MDL, including nationwide briefings, witness preparation and global strategy.

Notable practitioners

Michael Imbroscio
is "an outstanding lawyer" who is renowned for his strengths in strategy and briefing on mass torts, especially in the pharmaceutical sector. "He's brilliant - a true product liability lawyer's lawyer," states a source. "He's the calm in the storm,  he's unflappable and maintains the same even temperament."

Paul Schmidt
cochairs the firm's product liability group. He is highly experienced both in trial and at appeal, with particular strength in pharmaceutical litigation and toxic torts. "Paul Schmidt is one of the finest lawyers that I've ever had the pleasure to work with," states a source. "He's a brilliant tactician. He's very smart and a very good trial lawyer - he has the complete skill set."

Phyllis Jones
is an esteemed trial lawyer in pharmaceutical defense who comes recommended by interviewees as a "talented attorney." Her caseload includes opioid litigation and disputes regarding Pradaxa.